Skip to Main Content

Paper Details

Aneustat (OMN54) has aerobic glycolysis-inhibitory activity and also immunomodulatory activity as indicated by a first-generation PDX prostate cancer model.
Int J Cancer
6
2018
Author NameAffiliation
Hui Xue
Dong Lin
Dong Lin
Colin C Collins
Colin C CollinsUniversity of British Columbia
Martin E Gleave
Martin E GleaveUniversity of British Columbia
Yuzhuo Wang
Yuzhuo Wang
Yuzhuo WangUniversity of British Columbia
Yuzhuo WangUniversity of British Columbia
  • 1 - 11

Datasets

Release 1.2